Disagreement between patient- and physician-reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.

Cancer Medicine
Akira OokiKensei Yamaguchi

Abstract

The status and prognostic value of the disagreement between physician and patient assessments of symptomatic adverse events (AEs) remain unclear for patients with metastatic colorectal cancer treated with first-line cetuximab plus chemotherapy. Paired data on patient-reported outcomes using the EORTC QLQ-C30 and physician-reported outcomes using the NCI-CTCAE for eight symptomatic AEs (fatigue, pain, insomnia, dyspnea, constipation, appetite loss, nausea/vomiting, and diarrhea) were collected from a prospective trial assessing the relationships between treatment efficacy, AEs, and quality of life. The overall agreement rates between patient and physician reporting at 4 weeks ranged from 40.2% to 76.5% for 129 patients. The level of agreement based on Cohen's κ statistics was slight to poor for dyspnea, pain, fatigue, and insomnia, while it was moderate to fair for the remaining AEs. No clinicopathological characteristics of disagreement were found. The underreporting by physicians ranged from 12.5% (nausea/vomiting) to 56.7% (fatigue). The 2-year overall survival (OS) rate was more favorable for patients with high agreement than for those with low agreement (71.2% vs. 46.5%, p = .016), and the agreement status was an independen...Continue Reading

References

Jan 1, 1990·Journal of Clinical Epidemiology·D V Cicchetti, A R Feinstein
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D OsobaJ Pater
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Erik K FrommeTomasz M Beer
Nov 28, 2007·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C ByrneF Efficace
Mar 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heather-Jane AuDerek J Jonker
Nov 19, 2009·Journal of the National Cancer Institute·Ethan BaschDeborah Schrag
Mar 12, 2010·The New England Journal of Medicine·Ethan Basch
Dec 14, 2011·Journal of the National Cancer Institute·Chantal QuintenAndrew Bottomley
Jun 16, 2012·Journal of Pain and Symptom Management·Alla SikorskiiSuzie Ahn
Aug 18, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Petrelli, S Barni
Oct 16, 2013·Cancer·Chantal QuintenUNKNOWN Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer
Jan 24, 2015·Dermatology : International Journal for Clinical and Investigative Dermatology·M K A BasraA Y Finlay
Jan 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo Di MaioFrancesco Perrone
Dec 9, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ethan BaschDeborah Schrag
Dec 31, 2015·Journal of the National Cancer Institute·Efstathios ZikosUNKNOWN EORTC PROBE
Jan 21, 2016·Nature Reviews. Clinical Oncology·Massimo Di MaioFrancesco Perrone
Feb 12, 2017·Journal of Pain and Symptom Management·Kavita D ChandwaniMichael J Fisch
Apr 20, 2017·Journal of the National Cancer Institute·Fabrice DenisChristophe Letellier
Jun 7, 2017·JAMA : the Journal of the American Medical Association·Ethan BaschDeborah Schrag
Oct 5, 2017·Nature Reviews. Clinical Oncology·Thomas W LeBlanc, Amy P Abernethy
Nov 21, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T YoshinoJ-Y Douillard
Aug 1, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Claudia RutherfordMadeleine King

❮ Previous
Next ❯

Software Mentioned

JMP
QUACK
SAS

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.